--- title: "12 Health Care Stocks Moving In Monday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/281782554.md" description: "In Monday's intraday session, several health care stocks experienced significant movements. Profusa (NASDAQ:PFSA) surged 148% to $1.88, while IO Biotech (NASDAQ:IOBT) rose 53.25% to $0.05. Other gainers included PRF Technologies (NASDAQ:PRFX) up 32.38% to $2.78, and Soleno Therapeutics (NASDAQ:SLNO) up 32.37% to $52.27. Conversely, Akari Therapeutics (NASDAQ:AKTX) fell 23.9% to $3.4, and Viridian Therapeutics (NASDAQ:VRDN) decreased by 22.64% to $14.57. Aditxt (NASDAQ:ADTX) and Lunai Bioworks (NASDAQ:LNAI) also saw declines of 22.27% and 19.92%, respectively." datetime: "2026-04-06T17:05:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281782554.md) - [en](https://longbridge.com/en/news/281782554.md) - [zh-HK](https://longbridge.com/zh-HK/news/281782554.md) --- # 12 Health Care Stocks Moving In Monday's Intraday Session ### Gainers - **Profusa** (NASDAQ:PFSA) shares rose 148.0% to $1.88 during Monday's regular session. The market value of their outstanding shares is at $1.0 million. - **IO Biotech** (NASDAQ:IOBT) shares rose 53.25% to $0.05. The market value of their outstanding shares is at $2.3 million. - **PRF Technologies** (NASDAQ:PRFX) shares increased by 32.38% to $2.78. The market value of their outstanding shares is at $1.7 million. - **Soleno Therapeutics** (NASDAQ:SLNO) stock rose 32.37% to $52.27. The market value of their outstanding shares is at $2.1 billion. - **Estrella Immunopharma** (NASDAQ:ESLA) shares increased by 27.61% to $1.34. The market value of their outstanding shares is at $44.7 million. - **ABVC BioPharma** (NASDAQ:ABVC) stock increased by 25.68% to $1.37. The company's market cap stands at $27.7 million. ### Losers - **Akari Therapeutics** (NASDAQ:AKTX) shares fell 23.9% to $3.4 during Monday's regular session. The company's market cap stands at $159.7 million. - **Viridian Therapeutics** (NASDAQ:VRDN) shares decreased by 22.64% to $14.57. The market value of their outstanding shares is at $1.7 billion. - **Aditxt** (NASDAQ:ADTX) shares declined by 22.27% to $0.62. - **Lunai Bioworks** (NASDAQ:LNAI) shares declined by 19.92% to $0.3. The market value of their outstanding shares is at $9.0 million. - **Cyclerion Therapeutics** (NASDAQ:CYCN) stock fell 19.68% to $4.94. The market value of their outstanding shares is at $23.4 million. - **Polaryx Therapeutics** (NASDAQ:PLYX) stock declined by 19.61% to $5.74. The market value of their outstanding shares is at $338.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [PRFX.US](https://longbridge.com/en/quote/PRFX.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [IOBT.US](https://longbridge.com/en/quote/IOBT.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [SLNO.US](https://longbridge.com/en/quote/SLNO.US.md) - [IOBTQ.US](https://longbridge.com/en/quote/IOBTQ.US.md) ## Related News & Research - [HRT Financial LP acquires 1,310 Profusa shares for $1,323.1](https://longbridge.com/en/news/294404239.md) - [12:25 ETRaymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)](https://longbridge.com/en/news/292931199.md) - [U.S. kindergarten vaccine coverage falls, CDC says](https://longbridge.com/en/news/296136711.md) - [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md) - [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)